The Critical Path Institute (AZ, USA) have announced support from the European Medicines Agency (London, UK) for the measurement of glutamate dehydrogenase as a biomarker of hepatocellular live injury.
Improved efficiency in neonatal diagnostics promised with the launch of a new device from PerkinElmer Inc (MA, USA).
Researchers have demonstrated that small molecules mimicking activated protein C could provide anti-inflammatory and anti-thrombotic protection without interfering with blood clotting, becoming attractive drug candidates.
Wacker Biotech GmbH (Jena, Germany) have announced that they will manufacture the active ingredient in the drug Retavase®. This drug has obtained FDA approval to treat acute myocardial infarction in adults.
2D-LC–MS/MS to measure cleaved high-molecular-weight kininogen in human plasma as a biomarker for C1-INH-HAE
This research article describes a reagent-free LC–MS assay that has been developed for the quantitation of cHMWK, which was shown to be elevated in plasma of C1-INH-HAE patients due to C1-INH deficiency relative to that of healthy subjects.
A Swedish research team has identified a method of drug and disease detection through the analysis of various compounds in exhaled breath.
Researchers from Wayne State University School of Medicine (MI, USA) have indicated that RNA from sperm could be a promising determinant for a successful live birth and an indicator for the health of the child as they mature.
The first biosimilar for the treatment of breast and stomach cancers has been approved by the FDA, termed Ogivri.
Mass spectrometry based metabolomics: a novel analytical technique for detecting metabolic syndrome?
This editorial discusses the use of mass spectrometry metabolomics as a diagnositic tool for detecting metabolic syndrome. Learn more in this article from Bioanalysis.
In this commentary, Melanie Anderson discusses the use of paper-based dried sampling technologies and how they can provide opportunities to collect biological samples in the dried state, which involves significantly smaller sample volumes than traditional sample collection approaches.